Antimicrobial susceptibilities of group B Streptococci in New Zealand [1]

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 8, 2003, Pages 2710-2711

  Werno, Anja M ^a   Anderson, Trevor P ^a   Murdoch, David R ^a,b  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; ERYTHROMYCIN; MEROPENEM; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CHILD; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND; NEWBORN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; NEW ZEALAND; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0042267906     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.8.2710-2711.2003     Document Type: Letter

References (16)

1. Azavedo, J. C., M. McGavin, C. Duncan, D. E. Low, and A. McGeer. 2001. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45:3504-3508.
2. Bland, M. L., S. T. Vermillion, D. E. Soper, and M. Austin. 2001. Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. Am. J. Obstet. Gynecol. 184:1125-1126.
3. De Mouy, D., J. D. Cavallo, R. Leclercq, R. Fabre, and AFORCORPI-BIO Network. 2001. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study. Antimicrob. Agents Chemother. 45:2400-2402.
4. Fernandez, M., M. E. Hickman, and C. J. Baker. 1998. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob. Agents Chemother. 42:1517-1519.
5. Grimwood, K., P. R. Stone, I. A. Gosling, R. Green, B. A. Darlow, D. R. Lennon, and D. R. Martin. 2002. Late antenatal carriage of group B Streptococcus by New Zealand women. Aust. N. Z. J. Obstet. Gynecol. 42:182-186.
6. Hsueh, P. R., L. J. Teng, L. N. Lee, S. W. Ho, P. C. Yang, and K. T. Luh. 2001. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45:3205-3208.
7. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34:482-492.
8. Lin, F.-Y. C., P. H. Azimi, L. E. Weisman, J. B. Philips, J. Regan, P. Clark, G. G. Rhoads, J. Clemens, J. Troendle, E. Pratt, R. A. Brenner, and V. Gill. 2000. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin. Infect. Dis. 31:76-79.
9. Morales, W. J., S. S. Dickey, P. Bornick, and D. V. Lim. 1999. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am. J. Obstet. Gynecol. 181:310-314.
10. Murdoch, D. R., and L. B. Reller. 2001. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective. Antimicrob. Agents Chemother. 45:3623-3624.
11. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 5th ed. NCCLS document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
12. Pearlman, M. D., C. L. Pierson, and R. G. Faix. 1998. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet. Gynecol. 92:258-261.
13. Rouse, D. J., W. W. Andrews, F.-Y. C. Lin, C. W. Mott, J. C. Ware, and J. B. Philips. 1998. Antibiotic susceptibility profile of group B Streptococcus acquired vertically. Obstet. Gynecol. 92:931-934.
14. Seppälä, H., A. Nissinen, Q. Yu, and P. Huovinen. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
15. Stylianopoulos, A., N. Kelly, and S. Garland. 2002. Is penicillin and/or erythromycin resistance present in clinical isolates of group B Streptococcus in our community? Aust. N. Z. J. Obstet. Gynecol. 42:543-544.
16. Tyrrell, G. J., L. D. Senzilet, J. S. Spika, D. A. Kertesz, M. Alagaratnem, M. Lovgren, J. A. Talbot, and the Sentinel Health Unit Surveillance System Site Coordinators. 2000. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study. J. Infect. Dis. 182:168-173.